Cancer Medicine (Jul 2023)

Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer

  • Natalie Herold,
  • Johanna Schmolling,
  • Corinna Ernst,
  • Beyhan Ataseven,
  • Britta Blümcke,
  • Birgid Schömig‐Markiefka,
  • Sebastian Heikaus,
  • Uwe‐Jochen Göhring,
  • Christoph Engel,
  • Björn Lampe,
  • Kerstin Rhiem,
  • Philipp Harter,
  • Jan Hauke,
  • Rita K. Schmutzler,
  • Eric Hahnen

DOI
https://doi.org/10.1002/cam4.6214
Journal volume & issue
Vol. 12, no. 14
pp. 15256 – 15260

Abstract

Read online

To assess the role of germline pathogenic variants (PVs) in SMARCA4 and further established ovarian cancer (OC) predisposition genes in early onset OC, we investigated a clinical cohort of 206 unrelated OC index patients with an age at diagnosis of OC ≤40 years using an extended panel of 24 (candidate) cancer predisposition genes. PVs in established OC predisposition genes were most frequent in patients with high grade serous OC (21/62, 33.9%), comparatively rare in patients with epithelial OC other than high grade serous (5/74, 6.8%) or borderline ovarian tumours (2/39, 5.1%) and absent in mucinous OC (0/27). We demonstrate that germline PVs in SMARCA4 unlikely predispose for early onset OC other than SCCOHT.

Keywords